PIII icon

P3 Health Partners

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 87.5%
Negative

Neutral
Business Wire
28 days ago
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3.
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
Neutral
PRNewsWire
1 month ago
Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025.
Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States
Neutral
Seeking Alpha
2 months ago
P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.
P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
Neutral
Business Wire
2 months ago
P3 Health Partners Announces Second Quarter 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp.
P3 Health Partners Announces Second Quarter 2025 Results
Neutral
Business Wire
2 months ago
P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Sec.
P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call
Neutral
GlobeNewsWire
2 months ago
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Neutral
GlobeNewsWire
2 months ago
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Neutral
GlobeNewsWire
4 months ago
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Negative
Zacks Investment Research
4 months ago
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for P3 Health Partners (PIII), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now